One beguiling alternative to antibiotics for treating multi-drug resistant infections are Bdellovibrio-and-like-organisms (BALOs), predatory bacteria known to attack human pathogens. Consequently, in this study, the responses from four cell lines (three human and one mouse) were characterized during an exposure to different predatory bacteria, Bdellovibrio bacteriovorus HD100, Bacteriovorus BY1 and Bacteriovorax stolpii EB1. TNF-α levels were induced in Raw 264.7 mouse macrophage cultures with each predator, but paled in comparison to those obtained with E. coli. This was true even though the latter strain was added at an 11.1-fold lower concentration (p < 0.01). Likewise, E. coli led to a significant (54%) loss in the Raw 264.7 murine macrophage viability while the predatory strains had no impact. Tests with various epithelial cells, including NuLi-1 airway, Caco2, HT29 and T84 colorectal cells, gave similar results, with E. coli inducing IL-8 production. The viabilities of the NuLi-1 and Caco-2 cells were slightly reduced (8%) when exposed to the predators, while T84 viability remained steady. In no cases did the predatory bacteria induce actin rearrangement. These results clearly demonstrate the gentle natures of predatory bacteria and their impacts on human cells.
Bdellovibrio-and-like organisms (BALOs) are small Gram-negative δ-proteobacteria that are able to predate upon, enter and kill other Gram-negative bacteria1. They are ubiquitous in nature, ranging from terrestrial and aquatic environments2,3 to the gut of healthy human individuals4. Predatory bacteria employ multiple strategies to attack and/or kill their host bacteria5. Perhaps the best studied strategy involves them invading the periplasm of other Gram-negative bacteria, where they undergo a complex developmental cycle that terminates the prey cell viability and ultimately leads to the release of the predator’s progeny6. These organisms can predate upon a wide range of pathogenic bacterial strains in both planktonic7 and biofilm environments8,9,10,11,12. Moreover, the alleged dynamics of the predator-prey relationship that lead to a successful predation have recently been revealed13. Due to their unique bactericidal property, bacterial predators, including Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus, are being considered as promising antibacterial agents, particularly against human pathogens6.
The number of infectious diseases caused by pathogenic bacteria that have become resistant to commonly administered antibiotics is a burning issue in medicine. As a result, increasingly more infections are becoming difficult to treat using traditional antimicrobial agents14,15,16,17. A case in point is the recent emergence of MCR-1 in China, which represents a breach in the effectiveness of the last group of antibiotics, polymyxins, by plasmid-mediated resistance18. Although currently confined to China, MCR-1 is likely to emulate and follow the spread of other global resistance mechanisms, such as carbapenem-resistant NDM-1 (New Delhi metallo-beta-lactamase-1) Gram-negative strains19. Another major difficulty in pathogen eradication is “biofilms”, a surface-adherent structure formed by various bacteria, including pathogens. Biofilms pose an additional hurdle as they can be up to thousand times more resistant to antimicrobial agents than their planktonic counterparts20,21. With all these concerns, it is highly demanding that some effective alternative strategies should be made available in order to fight multi-drug resistant (MDR) infections. One novel strategy is using specific bacteriophage as a biological therapeutic for controlling the infectingpathogen22,23.
Predatory bacteria, which have also been proposed as a potential agent to address multidrug resistant pathogens, present several advantages over the use of antimicrobial drugs1,6. A few recent studies assessed the susceptibility of human pathogens to predation by Bdellovibrio spp. and other predatory bacteria, showing that these predators successfully reduce pathogen numbers under laboratory conditions7,24. However, the safety and efficacy of these predatory bacteria, particularly in regards to their cytotoxicity or inflammatory response, have remained relatively unstudied until very recently, with only a couple of studies touching on these important issues25,26,27.
Moreover, although in vitro and in vivo tests have been performed with predatory bacteria in various mammals, such as mice, rabbits and guinea pigs25,28, even non-pathogenic Gram-negative bacteria can reportedly elicit an inflammatory response from cultured epithelial cells29,30,31. This response is thought to be a leading cause of inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC)32, within humans. Consequently, this study was undertaken to investigate the inflammatory and/or cytotoxic effect of predatory bacteria, which are both Gram-negative and non-pathogenic to humans1, with several different mammalian cell lines. Our study sheds light on interactions between predatory bacteria and human cells and provides novel insight into the potential use predatory bacteria as live antimicrobial agents.
Effect of Predatory Bacteria on Murine Macrophage Raw 264.7 Cells
The criteria selected to evaluate the responses of the different mammalian cells to predatory bacteria in this study included the production of cytokines, their viability and any observable phenotypic changes. All exposures were performed with a bacteria-to-mammalian cell multiplicity of infection (MOI) of 111 for the non-predatory bacterial strains and 1230 for the predatory strains. This higher predator concentration was selected to demonstrate the safety of these microorganisms. As shown in Fig. 1A, treatment of the macrophage cells for six hours with the Bdellovibrio bacteriovorus strains, i.e., B. bacteriovorus HD100 or BY1, induced significantly lower amounts of TNF-α (300 and 72 pg/ml, respectively) when compared to E. coli MG1655 (607 pg/ml). This E. coli strain was selected since it was the prey used for cultivating the predatory strains as well as a representative non-pathogenic Gram-negative γ-proteobacteria species. TNF-α induction with the third predatory strain, Bacteriovorax stolpii EB1, was likewise significantly lower (241 pg/ml) when compared to the E. coli strain. As noted above, the number of predatory bacteria per macrophage was approximately 10-fold higher than with E. coli. As such, the lower responses seen with the predators are all the more impressive given their significantly higher numbers present. ELISAs performed for IL-12 using the same samples found this pro-inflammatory cytokine was not induced by the predatory strains (Figure S1).
We next examined the 24 hour viability of the Raw 264.7 macrophage cells, as this may account for the reduced TNF-α or IL-12 production in response to the predatory bacteria. However, none of the predatory bacterial strains elicited a cytotoxic response, with macrophage viabilities greater than 96% when compared with the untreated media controls (Fig. 1B). In contrast, macrophage populations treated with E. coli MG1655 in parallel saw a 53% reduction in their viabilities (Fig. 1B), a result that is most likely due to overgrowth of this bacterial strain. Microscopic observation of the Raw 264.7 cells exposed to the predatory bacterial strains also revealed healthy macrophage populations in each case as no actin stress fiber formation was evident, a result that is in stark contrast to cells treated with Y. pseudotuberculosis YPIII strain (Fig. 1). These results suggest that predatory bacteria are only weakly immunogenic or active in inducing pro-inflammatory responses when exposed to immune cells like monocyte macrophages and that they are not cytotoxic.
Effect of Predatory Bacteria on Lung Epithelial NuLi-1
Given the promising results above, we next performed similar experiments with cells derived from different locations within the human body to determine if they interact differently with the predatory strains. Initially we chose to test NuLi-1 airway epithelial cells with all three predatory strains and E. coli MG1655. After treating the cells for 6 hours and collecting samples, ELISA tests were performed to measure several pro- and anti-inflammatory cytokines. As shown in Fig. 2, both IL-6 and IL-10 were not induced by the presence of the predatory bacterial strains. Production of two pro-inflammatory cytokines, IL-8 and TNF-α, was likewise unaffected by the predatory cells. For comparison, tests were also performed in parallel with E. coli MG1655, which elicited a strong IL-8 response from the NuLi-1 cells.
The gentle nature of the predatory strains towards human cells was further affirmed in the microscopic images of the exposed NuLi-1 cells in Fig. 2. These human cells appear unperturbed by the predatory strains, with no clear β-actin stress fiber formation or morphological changes obvious. Similar results were obtained when E. coli MG1655 was tested, although some of the cells were noticeably larger, suggesting that they may be experiencing a giant cell phenotype. In contrast, actin stress fiber formation was quite evident when Y. pseudotuberculosis YPIII was tested (Fig. 2).
Effects of Predatory Bacteria on Intestinal Epithelial Cells
As the results above show all three predatory bacterial strains caused no obvious harm to NuLi-1 airway epithelial cells, we next analyzed their impacts on various intestinal epithelial cells (IECs). As with the NuLi-1 cells, ELISA’s were performed once more to determine the concentrations of the four pro- and anti-inflammatory cytokines produced in polarized T84 cell cultures (Figure S2) after a 6 hour exposure (Fig. 3). The cytokine responses from the T84 colorectal cells were basically identical to those from NuLi-1 cell cultures, namely that only IL-8 was induced and this from an exposure to E. coli MG1655. None of the predatory bacterial strains tested significantly induced the production of the cytokines tested with this cell line (Fig. 3). Images of the T84 cells taken after a 4-hour exposure likewise found no clear morphological changes resulting from the predatory bacteria.
Similar results were seen with two additional IECs, i.e., HT29 and Caco-2 cells (Figs 4 and 5, respectively). The cytokine production profile for HT29 cells was nearly identical as that for T84, except that B. bacteriovorus HD100 and B. stolpii EB1 both led to slight, yet significant, inductions of IL-8 (Fig. 4). Given that the number of predatory bacteria added was ten-fold higher than that for E. coli MG1655, these responses are mild by comparison. The cytokine results for Caco-2 were also similar with T84 except that TNF-α production was also strongly induced in the former cell line by E. coli MG1655. For all three IECs tested, the IL-10 levels remained constant or were reduced during exposure to the various bacterial strains. Once more, the predatory microbes had no obvious impact on the HT29 and Caco-2 IEC morphologies (Figs 4 and 5, respectively).
Human Epithelial Cell Viabilities
Using the same bacteria-to-human cell MOIs, i.e., 1230:1 and 111:1 for the predatory strains and E. coli MG1655, respectively, we next determined the impact each strain had on the 24 hour viability of the NuLi-1 cell cultures and IECs. For NuLi-1 cultures, the viability in the presence of the predatory strains was ≥90%, but dropped by 50% when exposed to E. coli MG1655 (Fig. 6). Of the IECs, the T84 cell cultures were the most robust epithelial cell tested since E. coli MG1655 reduced the viability by only 7% (Fig. 6). By comparison, HT29 and Caco-2 were much more susceptible to E. coli MG1655, with viability losses of 74% and 85%, respectively.
These results are in agreement with the live/dead images obtained for each cell type, including the Raw 246.7 cells (Fig. 7). For each cell type, the live cells fluoresce green while those that are dead or dying are red or yellow in color. It is clear from the images that E. coli MG1655 significantly impacted all of the cells tested in this study, leading to either a substantial loss in viability (Raw 246.7) or a reduced surface coverage (epithelial cells). For each of the predators, however, the results were basically identical with those in the media control. This is further confirmed in the ImageJ analyses where the relative number of green pixels, which correspond to the live cells, decreased when the cells were exposed to E. coli MG1655 but not the predatory cells.
With the current state of emerging multidrug-resistant pathogens, research into areas of microbiology and infectious disease that show promise towards the development of antimicrobial agents or strategies is rapidly increasing in significance. One novel approach that might hold the potential to treat antibiotic resistant infections is predatory bacteria6. Bdellovibrio strains, and other predatory bacteria, have long been proposed as a future alternative for antimicrobial therapy, particularly for external use such as in infected skin wounds1. The gentle nature of predatory bacteria towards human cells was hinted at in a previous study where epithelial cells exposed to a human pathogen were protected by the activity of B. bacteriovorus HD10033. Furthermore, their safety in mammalian systems has recently been addressed in an in vivo mouse model25. However, their effect on humans is an area of research that has not been thoroughly examined, either in vitro or in vivo.
In this study, we corroborated the effect of predatory bacteria on both cultured murine macrophage and human epithelial cell lines. Initially, mouse Raw 264.7 monocyte-macrophage cells were used as a representative immune cell to determine how they respond to three different predatory bacterial isolates, two Bdellovibrio spp. (HD100 and BY1) and one Bacteriovorax spp. (EB1). Amongst these three bacterial strains, BY1 and EB1 were both isolated from aquatic environments and identified through 16 s genotyping and phylogenetic analyses (Figure S3). The ability of each of these strains to elicit inflammatory responses from the macrophage cultures was determined alongside E. coli MG1655, a common lab strain that was selected in this study as a representative Gram-negative enterobacterium. Our results found lower TNF-α and IL-12 cytokine induction levels with the predatory bacteria, which suggest that they likely have a lower endo-toxic activity associated with their cell membrane components34,35. This is quite in line with a study performed with human mononuclear cells (hMNC) where the authors showed that purified lipid A and LPS from B. bacteriovorus HD100 was less immunogenic than those from an E. coli K-12 strain36. Their study identified some basic differences in the cell wall components between host dependent predatory bacteria and their natural prey E. coli strain. Thus, it appears that the membrane components of both Bdellovibrio and Bacteriovorax spp. are inert, or at least less active in inducing pro-inflammatory innate immune responses from cultured Raw 264.7 murine macrophage cells.
Another recent study, performed by Shatzkes, K. et al.25, reported modest cytokine induction levels shortly after an intravenous injection of predatory bacteria into live mice25. These induced levels dropped to baseline readings within 18 hours. One significant difference between their study and ours is the level of TNF-α detected, which was higher here. This discrepancy, however, can be explained by the direct exposure of the predatory bacteria to these immune cells in this study rather than their dissemination throughout the circulatory system of a live mouse, which would disperse them throughout various anatomical locations. The lack of any cytotoxic nature against Raw 264.7 monocyte-macrophage cells suggests that the predatory strains lack of any secretory or membrane bound cytolytic proteins. Microscopic data also found no obvious physical or cytoskeletal alteration of the Raw 264.7 monocyte-macrophage cells upon exposure (Figs 1 and 7).
Our initial observation that predatory bacteria are less immunogenic and less cytotoxic to a professional immune cell further supports the idea that these bacteria are not harmful to eukaryotic cells. However, as this finding may not correlate with the responses from human cells, several cell lines from different tissues were selected for evaluation. As one of the earliest cytokine to be secreted by epithelial cells, IL-8 is typically induced in response to bacterial entry37 or foreign antigens like flagellin38 or invasion39 proteins through toll-like receptor-mediated NF-κB and the mitogen activated protein kinase (MAPK) pathway40. This was the case for E. coli MG1655, where an exposure to this bacterium led to an increased IL-8 production from NuLi-1 cells. As the pro-inflammatory cytokines IL-8 and TNF-α are a series of immunoregulatory molecules that control the pro-inflammatory cytokine response41,42, we next analyzed the levels of two additional cytokines, i.e., IL-6 and IL-10. Whereas IL-10 is classified as anti-inflammatory cytokine, IL-6 is cell-type dependent and can function either anti-inflammatory or pro-inflammatory43. Interestingly, the basal level expression of IL-6 in NuLi-1 culture was much higher than the other cell lines tested, even for the non-treated medium control. The concentration of this cytokine remained high in all replications of this experiment, and, as such, appears to be a natural phenomenon of these alveolar epithelial cells. In support of this, it was shown previously that NuLi-1 cells are good producers of IL-6, which in turn activates alveolar macrophages to fight infection44. Although this higher expression may act to mask the response from these cells, IL-6 production levels were not induced by either E. coli MG1655 or the predatory strains. Similar results were seen with both IL-10 and TNF-α.
Another group reportedly found predatory bacteria within the human gut4 and, thus, we also tested the impact of an exposure with several IECs, including T84 cells. As reported previously, a basolateral adhesion of the bacteria with differentiating T84 cells is required to induce pro-inflammatory IL-845. Consequently, polarized T84 cells were generated in trans-well inserts to permit an exposure at the basolateral surface. With T84 cells, no IL-8 induction was seen with the predatory strains while the addition of E. coli elicited a substantial production of this cytokine. Similar results were also seen in another study where a human corneal-limbal epithelial cell line responded similarly when exposed to either Bdellovibrio spp. or Pseudomonas aeruginosa PAO146. Furthermore, tests with two additional IECs, i.e., HT29 and Caco-2 cells, gave basically identical results. Only with HT29 cells did the predatory strains B. bacteriovorus HD100 and B. stolpii EB1 elicit an IL-8 response. However, although the impact was significant, it was still very mild when compared with the response resulting from an exposure to E. coli MG1655. Given the much higher addition of predatory cells (11.1-fold higher) than E. coli, this weaker response further affirms the results of Schwudke et al.36 that predatory bacteria are not strongly immunogenic.
None of the IECs showed increasedIL-6, IL-10 or TNF-α production levels when exposed to the predatory bacterial strains, further affirming that these strains elicit only a minimal inflammatory response from these human cells. In contrast, E. coli MG1655 led to a strong TNF-α production from Caco-2 cells. Exposure to this bacterium also led to a significant reduction in the IL-10 cytokine levels within Caco-2 and HT29 cultures. This loss, however, may be attributed in part to the impact E. coli MG1655 had on the viabilities of both human cell lines as both were very susceptible to this strain (Fig. 6). Their sensitivity was further verified in the live/dead experiments (Fig. 7), where the populations of both Caco-2 and HT29 were nearly completely eradicated by E. coli MG1655. In contrast, the live/dead results given in Fig. 7 support the MTT viability results (Fig. 6) as both show all three predatory strains are not harmful to the human cells tested.
Although the results affirm that predatory bacteria do not negatively impact the health of the mammalian cells tested here, it is clear that the responses varied somewhat between the cell lines. LPS is recognized by the immune system as a marker for the detection of bacterial and pathogen invasion, a response that is responsible for the development of inflammatory system47. Due the nature of the LPS-host defense interactions, dissimilarities in the inflammatory and immunological responses from the different human cell lines tested are to be expected. For example, the biophysical properties of LPS-binding proteins, like the MD-2 and Toll-like receptor 4 complex (MD-2–TLR4), and their mode of interaction with LPS determine the ability of LPS to activate the immune response48. Furthermore, not all cell lines produce every cytokine in response to bacterial invasion or their secretory proteins. With this in mind, we selected mammalian tissue culture models, like macrophages and IEC’s, which are known to secrete most, if not all, of the cytokines assayed for in this study. That being said, no single cell line can be classified as an absolutely perfect system for evaluating predatory bacteria and, as such, to minimize this natural limitation, an array of cells was assayed in this study.
Although the predatory bacteria did not induce cytokine production from or reduce the viabilities of the mammalian cells tested, they may still be detrimental. To delve deeper into some potential responses that may result, we next looked for the formation of any stress fibers during an exposure. The driving force of cellular motility, cytokinesis and vesicular trafficking processes depends on the dynamic remodeling of the actin cytoskeleton through assembly, disassembly and organization of actin filaments into functional networks. It is known that Rho family small GTPases regulate cytoskeletal dynamics and that Rho activity is required for the formation of actin stress fibers and focal contacts, which are known to be formed when bacteria invade human cells. Thus, actin rearrangement is an important physiological process that can be used to evaluate a eukaryotic cells response during the course of bacterial exposure or internalization. When the human cells were exposed to the invasive pathogen Yersinia pseudotuberculosis YPIII exhibited extensive actin stress fiber formation. This was expected as this Y. pseudotuberculosis YPIII is known to elicit this response49 and for this reason was used as a positive control. In stark contrast, cells exposed to the predatory bacteria displayed no apparent increase in actin stress fiber formation. This was true for each of the predatory strains, as well as E. coli MG1655. The lack of any response implies that predatory bacterial strains are non-invasive with respect to human cells.
In conclusion, this study sheds light on and partially alleviates a major concern related with predatory bacterial research, namely the safety issue connected with their potential use in humans. Our findings demonstrate that a high-level exposure to predatory bacteria is not harmful to human cells in vitro. This is particularly supported by the absence of any strong phenotype when the three human cells were exposed to the predatory strains, either in terms of their cytokine production levels, losses in viability or the formation of actin stress fibers. However, further studies are needed to fully establish the gentle nature of predatory bacteria towards eukaryotic hosts as all the tests here were performed in vitro using cell lines and cultures and may not reliably replicate the responses that would be seen within, say, a human host. The results presented here, though, help pave the way for future studies focusing on predatory bacteria and their in vivo efficacy against bacterial pathogens.
Bacterial Strain Isolation, Identification and Growth
Wild-type host dependent predatory Bdellovibrio bacteriovorus HD100 was purchased from the German Collection of Microorganisms and Cell Cultures (DSMZ). E. coli MG1655 was used as both the prey for cultivation of the predatory strains as well as a standard Gram-negative non-pathogenic bacterial strain for these experiments. Yersinia pseudotuberculosis strain YPIII (p-) was obtained from BEI Resources (Manassa, VA, USA).
The other predatory bacteria, B. bacteriovorus BY1 and Bacteriovorax stolpii EB1 were isolated from environmental samples following methods described elsewhere50 with slight modifications. Briefly, 10 grams of underwater sediment was collected from the Taehwa River near Ulsan, Republic of Korea and mixed with 20 ml of HEPES buffer containing Mg2+ and Ca2+ with swirling onto a dancing benchtop rotator (Twister, Vison Scientific, Korea) for two hours. The mixture was then centrifuged at 2900 × g for 5 minutes using a benchtop centrifuge machine (Eppendorf 5430R, Germany). The supernatant was collected, filtered through a 0.45 micron filter (Millex-Millipore Ltd, USA) and 5 ml was mixed with 1 ml of washed E. coli MG1655 in the same HEPES buffer (OD = 2). The predator-prey mixture was then incubated in a 30 °C shaking incubator for 2 hours at 200 rpm. Afterwards, 2 ml were mixed with 10 ml of DNB top agar supplemented with the salts and poured onto a bottom agar plate as described previously. Plates were incubated at 30 °C until clear plaques could be visualized. These plaques were then collected and sub-cultured with freshly prepared prey (E. coli).
The newly isolated predators were then identified via 16 s rDNA sequencing with the universal primers 27F/1492R primer set51 followed by phylogenetic analysis with MEGAversion 6 software52. Predatory and prey bacteria were cultured and maintained in DNB (dilute nutrient broth 1/10 dilution of NB containing both 2 mM CaCl2 and 3 mM MgCl2) and LB (10 g tryptone, 5 g NaCl, and 5 g yeast extract per liter) medium, respectively, according to the protocol describedpreviously53.
Cell Lines, Cultures and Construction of Monolayers
Murine monocyte macrophage Raw 264.7 cells, human colon carcinoma T84 cells and Caco2 were cultured in T75 flasks in Dulbecco’s Modified Eagles Medium (MEM, 1:1 with sodium bicarbonate (Life Technologies, USA)). DMEM with sodium bicarbonate was used for growth of HT29. Each media was substituted with L-glutamine, 10% heat inactivated fetal bovine serum and 100 μg/ml Normocin (Invivogen, USA). Human primary alveolar epithelial NuLi-1 cells were cultured similarly in Bronchial Epithelial Growth Medium (BEGM) supplemented with 100 μg/ml Normocin (Invivogen, USA) without FBS. Each cell line was cultured under 5% CO2 in a water-jacketed CO2 incubator until they were confluent. For the ELISA tests, approximately 4 × 104 cells were seeded in a well of regular 12 well tissue culture plates (SPL Life Sciences, South Korea). T84 intestinal epithelial cells were seeded onto 12 mm Costar® polystyrene (Corning Inc. USA) trans-well plates (0.3 μm pore size, 0.33 cm2 insert diameter, 106 cells/cm2 and allowed to grow for two weeks to obtain polarized epithelial cells. The trans-well inserts were equilibrated in culture medium for at least 2 hours before seeding. The media in each plate was changed as needed.
The bacterial suspensions used to treat the various mammalian cells were prepared from freshly grown bacterial culture as described elsewhere45. For the predatory bacterial strains, 24 hour cultures grown on E. coli MG1655 were used. These cultures were first filtered through 0.45 μm syringe filter (Millex-Millipore Ltd, USA) to remove residual prey and the filtrates were concentrated by spinning them down at 10,600 × g for 5 minutes, washed four times with sterile HEPES (pH 7.4) and finally suspended in the appropriate medium at a concentration of 2.5 ± 0.74 × 107 cells/ml. The media in the wells with the human cells was then replaced with 1 ml of this media containing the predatory strains.
For the E. coli strain, an overnight culture of E. coli MG1655 was diluted 100-fold in fresh LB and grown for 3 hours at 37 °C at 200 RPM, after which the cells were collected by centrifugation at 10,600 × g for 5 minutes and washed twice in HEPES. After determining the OD, appropriate dilutions of the bacteria in the appropriate media were prepared before initiating the exposure. The average predatory bacterium-to-human cell ratio used in the exposures was 1230 ± 371:1 while the E. coli-to-human cell ratio was approximately 111 ± 17:1. The actual number of bacteria administered was determined by serially diluting and plating to obtain the PFU/CFU numbers at 30 °C.
For the Raw 264.7, Caco2, HT29 and NuLi-1 cells, the cells were allowed to form monolayers for 24 hours in regular 12 well plates. Afterwards the medium was removed, the cells were washed with DPBS and then they were equilibrated with serum- and antibiotic-free medium for at least 2 hours before addition of the bacteria. Likewise, the polarized T84 monolayers grown on Costar® polystyrene trans-well plates were washed two times with DPBS and incubated in medium containing heat-inactivated fetal bovine serum without antibiotics for 1 to 2 h. After equilibration, the bacteria were added to the lower chamber to allow basolateral contact. After six hours of exposure, the cell culture supernatant samples (apical in case of trans-well plates) were collected and centrifuged at 3,900 × g for 20 min to pellet any residual bacteria and cells before cytokine measurement.
After collection of the cell culture suspensions, the samples were stored at −20 °C until needed. The cytokine levels in each of samples were measured using enzyme-linked immunosorbent assay (ELISA). Mouse TNF-α and IL-12 ELISA’s were performed with the samples collected from Raw 264.7 macrophage cultures. In a similar manner, the human pro-inflammatory IL-8 and TNF-α, the dual functioning IL-6 and the anti-inflammatory IL-10 ELISAs were performed using kits from R&D systems Inc. (USA) according to the manufacturer’s protocol. The values are expressed as pg/ml.
The impact of the bacteria on the 24 hour viability of the cultured eukaryotic cells was also determined with the MTT assay. After the 24 hour exposure, approximately 5 μg/ml of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide (MTT reagent, Life Technologies, USA) was added to each well and the plates were incubated at 37 °C for 2–4 hours in the dark. Subsequently, the media was thoroughly removed, about 400 μl of DMSO was added to each well and the plate was incubated with shaking (150 rpm) at room temperature for 15 minutes to allow the color to develop. The OD was measured at 540 nm and used as a proxy for the viability of the cultured mammalian cells.
Immunostaining and Confocal Microscopy
To inspect the cells for any morphological changes induced by exposure to the bacteria, confluent monolayers were prepared on Labtek™ II chambered cover glass (Nunc, Germany). Before treatment, i.e., addition of the bacteria, the mammalian cells were serum starved for at least 20 hours. Cells were then treated with the predatory bacteria (MOI 1230:1) and E. coli and Yersinia pseudotuberculosis strain YPIII (MOI 111:1) for 3 h. Subsequently, the mammalian cells were washed with DPBS and fixed with 3.7% paraformaldehyde (in PBS) for 20 min at room temperature. After fixing, the cells were washed with PBS and permeabilized with 0.1% Triton X-100 (Sigma Aldrich, USA) in PBS for 5 min. The actin cytoskeleton was then stained with a phalloidin-rhodamine solution (0.5 μg/ml in DPBS; Invitrogen, USA) for 30 min at room temperature. After washing the cells with DPBS, the cellular DNA was counter-stained with DAPI (1 μg/ml in PBS)(Life Technologies, USA) for 5 min at room temperature. These cells were then visualized using a laser confocal microscope LSM 700® and the captured images processed using Zen software (Carl-Zeiss, Germany).
Live/Dead Imaging and quantification
Live, dead and total cells were quantified by using two dyes, calcein AM and ethidium homodimer-1 (EthD-1), to stain the cells. The cells were prepared by seeding 2 × 104 cells/well in 12 well plates. After 24 hours cells were treated with either media alone, a predatory strain or E. coli MG1655 for 24 hours as mentioned above. The cells were then washed gently with 1X Dulbecco’s phosphate-buffered saline (DPBS) at room temperature.
To perform the assay, 400 μL mixture of the Live/Dead Assay reagents (containing approximately 1 μM calcein AM and 2 μM EthD-1 (Life Technologies, USA)) were added to each well. The cells were incubated at room temperature for 10 minutes and subsequently observed under a confocal microscope (LSM 700; Carl Zeiss, Germany). For each condition, five independent fluorescent images were taken and analyzed using ImageJ software (http://rsb.info.nih.gov/ij/). The surface coverage and the relative green and red portions for each cell line and treatment were determined using the ImageJ data.
The data is expressed as the mean with the standard deviations (SDs). An unpaired Student’s t test was used to analyze the data. P-values of <0.05 were considered statistically significant. All the experiments were repeated at least three times for error analysis.
How to cite this article: Monnappa, A. K. et al. Investigating the Responses of Human Epithelial Cells to Predatory Bacteria. Sci. Rep. 6, 33485; doi: 10.1038/srep33485 (2016).
Sockett, R. E. & Lambert, C. Bdellovibrio as therapeutic agents: a predatory renaissance? Nat Rev Microbiol 2, 669–675, 10.1038/nrmicro959 (2004).
Jurkevitch, E., Minz, D., Ramati, B. & Barel, G. Prey range characterization, ribotyping, and diversity of soil and rhizosphere Bdellovibrio spp. isolated on phytopathogenic bacteria. Appl Environ Microb 66, 2365–2371, 10.1128/Aem.66.6.2365-2371.2000 (2000).
Varon, M. & Shilo, M. Inhibition of the Predatory Activity of Bdellovibrio by Various Environmental-Pollutants. Microbial Ecol 7, 107–111, 10.1007/Bf02032492 (1981).
Iebba, V. et al. Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects. Plos One 8, e61608, 10.1371/journal.pone.0061608 (2013).
Martin, M. O. Predatory prokaryotes: An emerging research opportunity. J Mol Microbiol Biotechnol 4, 467–477 (2002).
Dwidar, M., Monnappa, A. K. & Mitchell, R. J. The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus. BMB Reports 45, 71–78, 10.5483/BMBRep.2012.45.2.71 (2012).
Dashiff, A., Junka, R. A., Libera, M. & Kadouri, D. E. Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus. J Appl Microbiol 110, 431–444, 10.1111/j.1365-2672.2010.04900.x (2011).
Monnappa, A. K., Dwidar, M., Seo, J. K., Hur, J. H. & Mitchell, R. J. Bdellovibrio bacteriovorus inhibits Staphylococcus aureus biofilm formation and invasion into human epithelial cells. Sci Rep 4, 3811, 10.1038/srep03811 (2014).
Dwidar, M., Hong, S., Cha, M., Jang, J. & Mitchell, R. J. Combined application of bacterial predation and carbon dioxide aerosols to effectively remove biofilms. Biofouling 28, 671–680, 10.1080/08927014.2012.701286 (2012).
Kadouri, D. & O’Toole, G. A. Susceptibility of biofilms to Bdellovibriobacteriovorus attack. Appl Environ Microb 71, 4044–4051, 10.1128/Aem.71.7.4044-4051.2005 (2005).
Kadouri, D. E. & Tran, A. Measurement of Predation and Biofilm Formation under Different Ambient Oxygen Conditions Using a Simple Gasbag-Based System. Appl Environ Microb 79, 5264–5271, 10.1128/Aem.01193-13 (2013).
Chanyi, R. M., Koval, S. F. & Brooke, J. S. Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus. Environ Microbiol Rep 8, 343–351, 10.1111/1758-2229.12384 (2016).
Rotem, O. et al. Cell-cycle progress in obligate predatory bacteria is dependent upon sequential sensing of prey recognition and prey quality cues. Proc Natl Acad Sci USA 112, E6028–E6037, 10.1073/pnas.1515749112 (2015).
Davis, K. A., Moran, K. A., McAllister, C. K. & Gray, P. J. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerging Infectious Diseases 11, 1218–1224 (2005).
Joseph, N. M. et al. Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens. J Infect Dev Ctries 4, 218–225 (2010).
Jung, J. Y. et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 10 (2010).
Smith, M. G. et al. Antimicrobial resistance and virulence gene profiles in multi-drug resistant enterotoxigenic Escherichia coli isolated from pigs with post-weaning diarrhoea. Vet Microbiol 145, 299–307, 10.1016/j.vetmic.2010.04.004 (2010).
Liu, Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis, 10.1016/S1473-3099(15)00424-7 (2015).
Nordmann, P., Cuzon, G. & Naas, T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9, 228–236 (2009).
Cos, P., Tote, K., Horemans, T. & Maes, L. Biofilms: An Extra Hurdle for Effective Antimicrobial Therapy. Curr Pharm Design 16, 2279–2295 (2010).
Hoiby, N., Bjarnsholt, T., Givskov, M., Molin, S. & Ciofu, O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35, 322–332, 10.1016/j.ijantimicag.2009.12.011 (2010).
Fukuda, K. et al. Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration. Plos One 7, 10.1371/journal.pone.0047742 (2012).
Gorski, A., Targonska, M., Borysowski, J. & Weber-Dabrowska, B. The Potential of Phage Therapy in Bacterial Infections of the Eye. Ophthalmologica 223, 162–165, 10.1159/000193293 (2009).
Van Essche, M. et al. Killing of anaerobic pathogens by predatory bacteria. Mol Oral Microbiol 26, 52–61, 10.1111/j.2041-1014.2010.00595.x (2011).
Shatzkes, K. et al. Examining the safety of respiratory and intravenous inoculation of Bdellovibrio bacteriovorus and Micavibrioaeruginosavorus in a mouse model. Sci Rep 5, 10.1038/srep12899 (2015).
Schwudke, D. et al. The obligate predatory Bdellovibrio bacteriovorus possesses a neutral lipid A containing alpha-D-mannoses that replace phosphate residues - Similarities and differences between the lipid As and the lipopolysaccharides of the wild type strain B-bacteriovorus HD100 and its host-independent derivative HI100. J Biol Chem 278, 27502–27512, 10.1074/jbc.M303012200 (2003).
Shanks, R. M. Q. et al. An Eye to a Kill: Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections. Plos One 8, 10.1371/journal.pone.0066723 (2013).
Verklova, Z. S. Study of the virulence, toxicity and immunogenicity of different strains of Bdellovibrio bacteriovorus. Gig Sanit 38, 10–13 (1973).
Haller, D. et al. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47, 79–87 (2000).
Haller, D. et al. Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunol 112, 310–320, 10.1111/j.1365-2567.2004.01874.x (2004).
Zargar, A. et al. Bacterial secretions of nonpathogenic Escherichia coli elicit inflammatory pathways: a closer investigation of interkingdom signaling. MBio 6, e00025, 10.1128/mBio.00025-15 (2015).
Podolsky, D. K. Inflammatory bowel disease. N Engl J Med 347, 417–429, 10.1056/NEJMra020831 (2002).
Dwidar, M., Leung, B. M., Yaguchi, T., Takayama, S. & Mitchell, R. J. Patterning bacterial communities on epithelial cells. Plos One 8, e67165, 10.1371/journal.pone.0067165 (2013).
Saito, S., Matsuura, M. & Hirai, Y. Regulation of lipopolysaccharide-induced interleukin-12 production by activation of repressor element GA-12 through hyperactivation of the ERK pathway. Clin Vaccine Immunol 13, 876–883, 10.1128/CVI.00075-06 (2006).
Decker, K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192, 245–261 (1990).
Schwudke, D. et al. The obligate predatory Bdellovibrio bacteriovorus possesses a neutral lipid A containing alpha-D-Mannoses that replace phosphate residues: similarities and differences between the lipid As and the lipopolysaccharides of the wild type strain B. bacteriovorus HD100 and its host-independent derivative HI100. J Biol Chem 278, 27502–27512, 10.1074/jbc.M303012200 (2003).
Eckmann, L., Kagnoff, M. F. & Fierer, J. Epithelial-Cells Secrete the Chemokine Interleukin-8 in Response to Bacterial Entry. Infection and Immunity 61, 4569–4574 (1993).
Harrison, L. M. et al. Vibrio cholerae Flagellins Induce Toll-Like Receptor 5-Mediated Interleukin-8 Production through Mitogen-Activated Protein Kinase and NF-kappa B Activation. Infection and Immunity 76, 5524–5534, 10.1128/Iai.00843-08 (2008).
Schulte, R. et al. Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J 14, 1471–1484 (2000).
Zheng, J., Meng, J. H., Zhao, S. H., Singh, R. & Song, W. X. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and toll-like receptor-mediated activation of NF-kappa B. Infection and Immunity 76, 4498–4508, 10.1128/Iai.01317-07 (2008).
Opal, S. M. & DePalo, V. A. Anti-inflammatory cytokines. Chest 117, 1162–1172, 10.1378/chest.117.4.1162 (2000).
Cavaillon, J. M. Pro- versus anti-inflammatory cytokines: Myth or reality. Cell Mol Biol 47, 695–702 (2001).
Scheller, J., Chalaris, A., Schmidt-Arras, D. & Rose-John, S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813, 878–888, 10.1016/j.bbamcr.2011.01.034 (2011).
Crestani, B. et al. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J Clin Invest 94, 731–740, 10.1172/JCI117392 (1994).
Schulte, R. & Autenrieth, I. B. Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation. Infection and Immunity 66, 1216–1224 (1998).
Shanks, R. M. et al. An Eye to a Kill: Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections. Plos One 8, e66723, 10.1371/journal.pone.0066723 (2013).
Rosenfeld, Y. & Shai, Y. Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 1758, 1513–1522, 10.1016/j.bbamem.2006.05.017 (2006).
Munford, R. S. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect Immun 76, 454–465, 10.1128/IAI.00939-07 (2008).
Bliska, J. B. Yop effectors of Yersinia spp. and actin rearrangements. Trends Microbiol 8, 205–208, 10.1016/S0966-842x(00)01738-8 (2000).
Jurkevitch, E. Isolation and classification of Bdellovibrio and like organisms. Curr Protoc Microbiol Chapter 7, Unit7B 1, 10.1002/9780471729259.mc07b01s26 (2012).
Wen, C. Q. et al. Molecular typing and identification of Bdellovibrio-and-like organisms isolated from seawater shrimp ponds and adjacent coastal waters. J Appl Microbiol 106, 1154–1162, 10.1111/j.1365-2672.2008.04081.x (2009).
Tamura, K., Stecher, G., Peterson, D., Filipski, A. & Kumar, S. MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0. Mol Biol Evol 30, 2725–2729, 10.1093/molbev/mst197 (2013).
Im, H., Kim, D., Ghim, C. M. & Mitchell, R. J. Shedding light on microbial predator-prey population dynamics using a quantitative bioluminescence assay. Microb Ecol 67, 167–176, 10.1007/s00248-013-0323-z (2014).
Research was sponsored by the Korea Health Industry Development Institute (KHIDI) (Grant No. HI13C13550000) and by the U.S. Army Research Office and the Defense Advanced Research Projects Agency (DARPA) and was accomplished under Cooperative Agreement Number W911NF-15-2-0027. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office, DARPA, or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation hereon. Yersinia pseudotuberculosis YPIII (p-) (NR-4376) was kindly provided by the NIH Biodefense and Emerging Infections Research Resources Repository (BEI Resources), NIAID,NIH. Our heartfelt gratitude also goes to Professor Sang Sun Yoon from Yonsei University College of Medicine for kindly providing us with the Raw 264.7 cell line used in this study. We also wish to express our thankfulness to the UNIST UCRF for providing access to the microscopes and facilities.
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Monnappa, A., Bari, W., Choi, S. et al. Investigating the Responses of Human Epithelial Cells to Predatory Bacteria. Sci Rep 6, 33485 (2016). https://doi.org/10.1038/srep33485
Applied Microbiology and Biotechnology (2020)
Frontiers in Bioengineering and Biotechnology (2020)
Journal of Oral Microbiology (2020)